Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04217772
Other study ID # OCTA-LZL
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date December 1, 2017
Est. completion date December 1, 2021

Study information

Verified date January 2020
Source Wenzhou Medical University
Contact Zhangliang Li, MD
Phone +8613968832833
Email lizhangliang0328@126.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of this study is to quantify and compare the foveal avascular zone (FAZ), the parafoveal and foveal vessel density of superficial (SCP) and deep capillary plexus (DCP) and retinal thickness in deprivation amblyopic eyes, fellow non-amblyopic eyes, and age-matched normal eyes, using optical coherence tomography angiography (OCTA). The FAZ, parafoveal and foveal SCP and DCP, and retinal thickness were measured in normal controls and at least 3 months postoperatively in children with unilateral cataract and compared between groups after adjusting for axial length and spherical equivalents.


Recruitment information / eligibility

Status Recruiting
Enrollment 100
Est. completion date December 1, 2021
Est. primary completion date December 1, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 3 Years to 18 Years
Eligibility Inclusion Criteria:

- children after cataract surgery and healthy volunteers

Exclusion Criteria:

- presence of corneal opacity preventing detailed imaging

- nystagmus

- retinal disease,

- persistent fetal vasculature

- intraocular inflammation,

- glaucoma

- vitreoretinal surgery

- premature birth

- neurologic disease

- systemic disease that could alter microvasculature (including diabetes, hypertension, cardiovascular disease and renal disease)

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Optical Coherence Tomography Angiography
A device testing the vascular density in the retina

Locations

Country Name City State
China Eye Hospital of WMU Hangzhou Zhejiang
China The affiliated Eye Hospital of Wenzhou Medical College Wenzhou Zhejiang

Sponsors (1)

Lead Sponsor Collaborator
Wenzhou Medical University

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary Foveal retinal thickness Foveal retinal thickness in microns up to 36 months
Primary Area of foveal avascular zone Area of foveal avascular zone in square microns up to 36 months